Page 178 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 178

Chapter 9a
neoplasia. Taiwanese journal of obstetrics & gynecology. 2012;51(4):533-8.
16. Baak JP, Kruse AJ, Robboy SJ, Janssen EA, van Diermen B, Skaland I. Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol.
2006;59(10):1017-28.
17. Canfell K, Barnabas R, Patnick J, Beral V. The predicted effect of changes in cervical screening
practice in the UK: results from a modelling study. British journal of cancer. 2004;91(3):530-6.
18. Follen M, Atkinson EN, Schottenfeld D, Malpica A, West L, Lippman S, et al. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions
of the cervix. Clin Cancer Res. 2001;7(11):3356-65.
19. Meyskens FL, Jr., Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, et al. Enhancement
of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. Journal of the National Cancer Institute. 1994;86(7):539-43.
20. Keefe KA, Schell MJ, Brewer C, McHale M, Brewster W, Chapman JA, et al. A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high- grade cervical intraepithelial neoplasia. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2001;10(10):1029-35.
21. Alvarez RD, Conner MG, Weiss H, Klug PM, Niwas S, Manne U, et al. The efficacy of 9-cis- retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2003;12(2):114-9.
22. Garcia F, Petry KU, Muderspach L, Gold MA, Braly P, Crum CP, et al. ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial. Obstetrics and gynecology. 2004;103(2):317-26.
23. Van Pachterbeke C, Bucella D, Rozenberg S, Manigart Y, Gilles C, Larsimont D, et al. Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo- controlled study. Gynecologic oncology. 2009;115(1):69-74.
24. Kaufmann AM, Nieland JD, Jochmus I, Baur S, Friese K, Gabelsberger J, et al. Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). International journal of cancer Journal international du cancer. 2007;121(12):2794-800.
176



















































































   176   177   178   179   180